News

Bioelectrix named Disruptor of the Year 2026 🏆

Bioelectrix has won the national Disruptor of the Year pitch competition at Innovation Night in Uppsala, taking the title and SEK 100,000 for its bioelectronic approach to chronic wound care.

Bioelectrix selected for HealthTech Venture Pulse 2026

Bioelectrix has been selected as one of twelve companies to present at HealthTech Venture Pulse 2026, bringing together some of Sweden’s most promising healthtech ventures with leading Nordic investors. More

Bioelectrix won Falling Walls Lab Gothenburg

We are proud to share that Bioelectrix has won Falling Walls Lab Gothenburg 2026, hosted by Chalmers University of Technology, with the pitch â€śBreaking the Wall of Bioelectric Wound Healing.” This recognition

Elektroniktidningen (ETN)

We’re excited to share that Elektroniktidningen (ETN) has published an article about Bioelectrix and the bioelectronic technology behind our wound care solution ⚡️ The piece highlights how controlled direct current stimulation can support the healing process

Building the health economics case for Bioelectrix

Bioelectrix is developing a new medical device to actively accelerate wound healing. The technology itself is important, but in wound care, strong technology is not enough. For a solution to

Bioelectrix joins CO-AX Accelerator at Sahlgrenska Science Park

Bioelectrix has been selected for the CO-AX Accelerator at Sahlgrenska Science Park, joining a cohort of health innovators shaping the next generation of healthcare solutions. As part of the program, Bioelectrix

Bioelectrix appoints Jan Hörling as new Chair of the Board

Bioelectrix is pleased to announce the appointment of Jan Hörling as our new Chair of the Board. Jan joins Bioelectrix at an exciting time as we continue to strengthen our strategy, build momentum,

Bioelectrix selected for the REACH 2025–26 cohort

Bioelectrix has been selected as one of eight Nordic deep-tech teams in the REACH 2025–26 cohort, a Silicon Valley–based incubator program run by Nordic Innovation House to accelerate the commercialisation

Bioelectrix explores the German market for clinical collaboration and growth

🇩🇪 Back from Germany — and energized about what’s ahead for Bioelectrix ⚡️ Bioelectrix recently traveled to Germany as part of a delegation focused on strengthening cross-border collaboration in healthcare innovation.